Description
Anastrozole is a powerful and highly selective non-steroidal aromatase inhibitor used to treat breast cancer after surgery and for metastases in both pre and post-menopausal women.
Indications
– Treatment of advanced breast cancer in postmenopausal women. Efficacy has not been demonstrated in oestrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.
– Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer.
– Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
Subject to medical prescription
Pharmaceutical form: 1 mg x 28 film-coated tablets
NHIF code: LF156 ICD: C50
